Ideal timing for testing: Before starting your GLP-1 medication (baseline) 4-6 weeks after starting treatment After any dose increase Quarterly during stable dosing Immediately if warning symptoms appear People at higher risk for electrolyte problems include those over 65, anyone with kidney disease, heart failure patients, people taking diuretics, and anyone with persistent GI symptoms lasting beyond the first 8-12 weeks of treatment
What drug interactions are there with Lexapro
doi: 10.1007/s11064-008-9646-4 28 AnFMChenSXuZYinLWangYLiuARet al
From a cost-effectiveness perspective, these drugs would have to translate to striking long-term health benefits for patients, such as a reduction in major cardiac events or an overall increase in time to dialysis
In pancreatic cells, proglucagon is cleaved to produce glucagon, glicentin-related pancreatic polypeptide (GRPP), intervening peptide-1 (IP-1), and the major proglucagon fragment (MPGF), constituting GLP-1, IP-2, and GLP-2
